Cargando…

Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis

BACKGROUND: A progressive lung disease and a worse survival have been observed in patients with systemic sclerosis and alveolitis. The objective of this study was to define the functional, radiological and biological markers of alveolitis in SSc patients. METHODS: 100 SSc patients (76 with limited a...

Descripción completa

Detalles Bibliográficos
Autores principales: De Santis, Maria, Bosello, Silvia, La Torre, Giuseppe, Capuano, Anna, Tolusso, Barbara, Pagliari, Gabriella, Pistelli, Riccardo, Danza, Francesco Maria, Zoli, Angelo, Ferraccioli, Gianfranco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208954/
https://www.ncbi.nlm.nih.gov/pubmed/16107215
http://dx.doi.org/10.1186/1465-9921-6-96
_version_ 1782124943113191424
author De Santis, Maria
Bosello, Silvia
La Torre, Giuseppe
Capuano, Anna
Tolusso, Barbara
Pagliari, Gabriella
Pistelli, Riccardo
Danza, Francesco Maria
Zoli, Angelo
Ferraccioli, Gianfranco
author_facet De Santis, Maria
Bosello, Silvia
La Torre, Giuseppe
Capuano, Anna
Tolusso, Barbara
Pagliari, Gabriella
Pistelli, Riccardo
Danza, Francesco Maria
Zoli, Angelo
Ferraccioli, Gianfranco
author_sort De Santis, Maria
collection PubMed
description BACKGROUND: A progressive lung disease and a worse survival have been observed in patients with systemic sclerosis and alveolitis. The objective of this study was to define the functional, radiological and biological markers of alveolitis in SSc patients. METHODS: 100 SSc patients (76 with limited and 24 with diffuse disease) underwent a multistep assessment of cardiopulmonary system: pulmonary function tests (PFTs) every 6–12 months, echocardiography, high resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL), if clinically advisable. Alveolar and interstitial scores on HRCT and IL-6 plasma levels were also assessed as lung disease activity indices. RESULTS: 90 SSc patients with abnormal PFTs and 3 with signs and/or symptoms of lung involvement and normal PFTs underwent HRCT and echocardiography. HRCT revealed evidence of fibrosis in 87 (93.5%) patients, with 55 (59.1%) showing both ground glass attenuation and fibrosis. In 42 patients who had exhibited ground glass on HRCT and consented to undergo BAL, 16 (38.1%) revealed alveolitis. 12 (75%) of these patients had restrictive lung disease (p < 0.0001) and presented diffuse skin involvement (p = 0.0009). IL-6 plasma levels were higher in patients with alveolitis than in patients without (p = 0.041). On logistic regression model the best independent predictors of alveolitis were diffuse skin involvement (OR(95%CIs):12.80(2.54–64.37)) and skin score > 14 (OR(95%CIs):7.03(1.40–34.33)). The alveolar score showed a significant correlation with IL-6 plasma levels (r = 0.36, p = 0.001) and with the skin score (r = 0.33, p = 0.001). Cultures of BAL fluid resulted positive in 10 (23.8%) of the 42 patients that underwent BAL and after one year a deterioration in PFTs occurred in 8 (80%) of these patients (p = 0.01). Pulmonary artery systolic pressure ≥ 40 mmHg was found in 6 (37.5%) patients with alveolitis. CONCLUSION: We found alveolitis only in 38.1% of the patients who had exhibited ground glass on HRCT and then underwent BAL, probably because the concomitant fibrosis influenced results. A diffuse skin involvement and a restrictive pattern on PFTs together with ground glass on HRCT were judged possible markers of alveolitis, a BAL examination being indicated as the next step. Nevertheless BAL would be necessary to detect any infections of the lower respiratory tract that may cause further deterioration in lung function.
format Text
id pubmed-1208954
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12089542005-09-16 Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis De Santis, Maria Bosello, Silvia La Torre, Giuseppe Capuano, Anna Tolusso, Barbara Pagliari, Gabriella Pistelli, Riccardo Danza, Francesco Maria Zoli, Angelo Ferraccioli, Gianfranco Respir Res Research BACKGROUND: A progressive lung disease and a worse survival have been observed in patients with systemic sclerosis and alveolitis. The objective of this study was to define the functional, radiological and biological markers of alveolitis in SSc patients. METHODS: 100 SSc patients (76 with limited and 24 with diffuse disease) underwent a multistep assessment of cardiopulmonary system: pulmonary function tests (PFTs) every 6–12 months, echocardiography, high resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL), if clinically advisable. Alveolar and interstitial scores on HRCT and IL-6 plasma levels were also assessed as lung disease activity indices. RESULTS: 90 SSc patients with abnormal PFTs and 3 with signs and/or symptoms of lung involvement and normal PFTs underwent HRCT and echocardiography. HRCT revealed evidence of fibrosis in 87 (93.5%) patients, with 55 (59.1%) showing both ground glass attenuation and fibrosis. In 42 patients who had exhibited ground glass on HRCT and consented to undergo BAL, 16 (38.1%) revealed alveolitis. 12 (75%) of these patients had restrictive lung disease (p < 0.0001) and presented diffuse skin involvement (p = 0.0009). IL-6 plasma levels were higher in patients with alveolitis than in patients without (p = 0.041). On logistic regression model the best independent predictors of alveolitis were diffuse skin involvement (OR(95%CIs):12.80(2.54–64.37)) and skin score > 14 (OR(95%CIs):7.03(1.40–34.33)). The alveolar score showed a significant correlation with IL-6 plasma levels (r = 0.36, p = 0.001) and with the skin score (r = 0.33, p = 0.001). Cultures of BAL fluid resulted positive in 10 (23.8%) of the 42 patients that underwent BAL and after one year a deterioration in PFTs occurred in 8 (80%) of these patients (p = 0.01). Pulmonary artery systolic pressure ≥ 40 mmHg was found in 6 (37.5%) patients with alveolitis. CONCLUSION: We found alveolitis only in 38.1% of the patients who had exhibited ground glass on HRCT and then underwent BAL, probably because the concomitant fibrosis influenced results. A diffuse skin involvement and a restrictive pattern on PFTs together with ground glass on HRCT were judged possible markers of alveolitis, a BAL examination being indicated as the next step. Nevertheless BAL would be necessary to detect any infections of the lower respiratory tract that may cause further deterioration in lung function. BioMed Central 2005 2005-08-17 /pmc/articles/PMC1208954/ /pubmed/16107215 http://dx.doi.org/10.1186/1465-9921-6-96 Text en Copyright © 2005 De Santis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
De Santis, Maria
Bosello, Silvia
La Torre, Giuseppe
Capuano, Anna
Tolusso, Barbara
Pagliari, Gabriella
Pistelli, Riccardo
Danza, Francesco Maria
Zoli, Angelo
Ferraccioli, Gianfranco
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
title Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
title_full Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
title_fullStr Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
title_full_unstemmed Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
title_short Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
title_sort functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208954/
https://www.ncbi.nlm.nih.gov/pubmed/16107215
http://dx.doi.org/10.1186/1465-9921-6-96
work_keys_str_mv AT desantismaria functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT bosellosilvia functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT latorregiuseppe functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT capuanoanna functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT tolussobarbara functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT pagliarigabriella functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT pistelliriccardo functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT danzafrancescomaria functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT zoliangelo functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis
AT ferraccioligianfranco functionalradiologicalandbiologicalmarkersofalveolitisandinfectionsofthelowerrespiratorytractinpatientswithsystemicsclerosis